Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology

ORCID: 0000-0002-1531-4294

Publication year:
All
51 - 60 out of 68Page size: 10
  1. 2022
  2. Published

    Multiomics signatures of type 1 diabetes with and without albuminuria

    Clos-Garcia, M., Ahluwalia, Tarun Veer Singh, Winther, S. A., Henriksen, P., Ali, M., Fan, Yong, Stankevic, Evelina, Lyu, Liwei, Vogt, J. K., Hansen, Torben, Legido-Quigley, C., Rossing, Peter & Pedersen, Oluf Borbye, 2022, In: Frontiers in Endocrinology. 13, 17 p., 1015557.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Non-dipping and higher nocturnal blood pressure are associated with risk of mortality and development of kidney disease in type 1 diabetes

    Hjortkjær, H., Persson, F., Theilade, S., Winther, S. A., Tofte, N., Ahluwalia, Tarun Veer Singh & Rossing, Peter, 2022, In: Journal of Diabetes and its Complications. 36, 9, 6 p., 108270.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Novel topical allogeneic bone-marrow-derived mesenchymal stem cell treatment of hard-to-heal diabetic foot ulcers: a proof of concept study

    Andersen, Jonas Askø, Rasmussen, A., Frimodt-Møller, M., Engberg, S., Steeneveld, E., Kirketerp-Møller, K., O’Brien, T. & Rossing, Peter, 2022, In: Stem Cell Research and Therapy. 13, 1, 280.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Organic Anion Transporter Gene Variants Associated With Plasma Exposure and Long-Term Response to Atrasentan in Patients With Diabetic Kidney Disease

    Smeijer, J. D., Koomen, J. V., Kohan, D. E., McMurray, J. J. V., Bakris, G. L., Correa-Rotter, R., Hou, F. F., Kitzman, D. W., Makino, H., Mayer, G., Nowicki, M., Perkovic, V., Rossing, Peter, Tobe, S., Parving, H. H., de Zeeuw, D. & Heerspink, H. J. L., 2022, In: Clinical Pharmacology and Therapeutics. 112, 5, p. 1098-1107

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Precision diagnostic approach to predict 5-year risk for microvascular complications in type 1 diabetes

    Al-Sari, N., Kutuzova, Svetlana, Suvitaival, T., Henriksen, P., Pociot, Flemming, Rossing, Peter, McCloskey, D. & Legido-Quigley, C., 2022, In: EBioMedicine. 80, 104032.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Quételet (body mass) index and effects of dapagliflozin in chronic kidney disease

    Chertow, G. M., Vart, P., Jongs, N., Langkilde, A. M., McMurray, J. J. V., Correa-Rotter, R., Rossing, Peter, Sjöström, C. D., Stefansson, B. V., Toto, R. D., Wheeler, D. C. & Heerspink, H. J. L., 2022, In: Diabetes, Obesity and Metabolism. 24, 5, p. 827-837 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Randomized Controlled Trial of the Hemodynamic Effects of Empagliflozin in Patients With Type 2 Diabetes at High Cardiovascular Risk: The SIMPLE Trial

    Wolsk, E., Jürgens, M., Schou, Morten, Ersbøll, M., Hasbak, P., Kjær, Andreas, Zerahn, B., Brandt, N. H., Gæde, P. H., Rossing, Peter, Faber, Jens, Inzucchi, S. E., Kistorp, Caroline Michaela Nervil & Gustafsson, Finn, 2022, In: Diabetes. 71, 4, p. 812-820 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis

    Stougaard, E. B., Kristensen, Peter Lommer, Kielgast, U., Andersen, H. U., Hamid, Y., Gæde, P. H., Søndergaard, E., Dørflinger, G. H., Fjeldborg, K. K., Hansen, K. W., Thomsen, H. H., Al-Imar, T. M. J., Røder, M., Sridhar, V. S., Cherney, D., Rossing, Peter & Persson, F., 2022, In: Diabetes & vascular disease research. 19, 5, p. 14791641221130043

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes

    Schnell, O., Battelino, T., Bergenstal, R., Blüher, M., Böhm, M., Brosius, F., Carr, R. D., Ceriello, A., Forst, T., Giorgino, F., Guerci, B., Heerspink, H. J. L., Itzhak, B., Ji, L., Kosiborod, M., Lalić, N., Lehrke, M., Marx, N., Nauck, M., Rodbard, H. W. & 10 others, Rosano, G. M. C., Rossing, Peter, Rydén, L., Santilli, F., Schumm-Draeger, P., Vandvik, P. O., Vilsbøll, Tina, Wanner, C., Wysham, C. & Standl, E., 2022, In: Cardiovascular Diabetology. 21, 1, 50.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial

    Wheeler, D. C., Jongs, N., Stefansson, B., Chertow, G. M., Greene, T., Hou, F. F., Langkilde, A. M., McMurray, J. J., Rossing, Peter, Nowicki, M., Wittmann, I., Correa-Rotter, R., Sjostrom, C. D., Toto, R. D., Heerspink, H. J. L. & DAPA-CKD Trial Comm Investigators, D. T. C. I., 2022, In: Nephrology Dialysis Transplantation. 37, 9, p. 1647–1656 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 12 3 4 5 6 7 Next

ID: 12937790